Announced Wed, 8 Jul · 12:40 IST
Compliance certificate for share dematerialization for Q1 FY27
Compliance View source PDF
ZYDUSLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.7%1-day move
₹1152.50
prior close
₹1169.80
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1+0.0-0.2-0.2+0.7-0.2-1.8-1.6+0.7-0.8————
Up moveDown movePending
AI summary
Zydus Lifesciences has submitted a routine compliance certificate under SEBI Regulation 74(5) for the quarter ended June 30, 2026. The certificate, issued by registrar MUFG Intime India, confirms that equity share certificates received for dematerialization during the quarter were properly verified, mutilated, cancelled, and the depository's name was substituted as the registered owner. This is a standard quarterly procedural filing required of all listed companies.
Likely market impact
No impact on shareholders. Routine regulatory compliance filing with no effect on stock price or business.